Factor | Group | No. of Patients | % TFS | No. at Risk* | p† |
---|---|---|---|---|---|
All patients | 39 | 69.2 | 5 | ||
Age (years) | ≤ 69 | 20 | 85.0 | 4 | |
> 69 | 19 | 52.6 | 1 | .025 | |
Hormonal therapy | no | 10 | 40.0 | 0 | |
yes | 29 | 79.3 | 5 | .016 | |
PGUM (grade) | 0–1 | 29 | 86.2 | 4 | |
2–3 | 10 | 20.0 | 1 | <.001 | |
PTV (cm3) | ≤ 105 | 20 | 80.0 | 2 | |
> 105 | 19 | 57.9 | 3 | .128 | |
PTV Dmax (Gy) | ≤ 84.3 | 21 | 76.2 | 3 | |
> 84.3 | 18 | 61.1 | 2 | .199 | |
Bladder V47 (%) | ≤ 28 | 20 | 75.0 | 3 | |
> 28 | 19 | 63.2 | 2 | .437 |